Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

BioSphere Benefits From Broader UFE Awareness, But Remains Short On Profit

Feb 14 2005

Related Content

InSightec ExAblate 2000 Approved For Uterine Fibroids; 3-Year Study Required

Oct 25 2004

Biocompatibles’ Drug-Eluting UFE Treatment Would Be Marketed By Terumo

Dec 01 2003

People In Brief

Jan 10 2005

More from Archive

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window